- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Mark Cuban, founder of the Mark Cuban Cost Plus Drug Company, told Inside Health Policy that assertions the TrumpRx direct-to-patient model only serves uninsured patients are inaccurate, adding that cash prices can become cheaper than insurance copays and that Cost Plus will accept insurance for drugs purchased through the TrumpRx platform when in-network.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us